AstraZeneca has formed a partnership with ... its large-molecule GLP-1/glucagon dual agonist cotadutide which has reached mid-stage testing for overweight and obesity in diabetics, chronic kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback